Metagenomi Therapeutics, Inc.
MGX
$1.46
-$0.02-1.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.24% | -32.95% | -31.65% | -30.98% | -8.44% |
| Total Receivables | -47.32% | 3.24% | -25.43% | -22.77% | -17.21% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.41% | -37.54% | -4.23% | -5.00% | 86.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.83% | -32.76% | -31.18% | -30.52% | -7.30% |
|
|
|||||
| Total Current Assets | -35.83% | -32.76% | -31.18% | -30.52% | -7.30% |
| Net Property, Plant & Equipment | -17.82% | -16.70% | -15.59% | -13.02% | -11.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.93% | 8.78% | 8.48% | 7.14% | -48.46% |
| Total Assets | -31.88% | -30.81% | -29.44% | -28.29% | -11.03% |
|
|
|||||
| Total Accounts Payable | 179.36% | -60.84% | -16.28% | -60.98% | -70.24% |
| Total Accrued Expenses | -19.53% | 14.20% | -41.45% | -11.84% | -24.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.74% | 18.63% | 2.08% | 27.86% | 63.17% |
| Total Finance Division Other Current Liabilities | -61.90% | -55.86% | -44.03% | -51.44% | -56.60% |
| Total Other Current Liabilities | -61.90% | -55.86% | -44.03% | -51.44% | -56.60% |
| Total Current Liabilities | -38.53% | -35.26% | -37.01% | -43.58% | -45.82% |
|
|
|||||
| Total Current Liabilities | -38.53% | -35.26% | -37.01% | -43.58% | -45.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.82% | -12.77% | -11.90% | -11.09% | -10.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -59.65% | -75.40% | -73.00% | -74.47% | -65.99% |
| Total Liabilities | -30.35% | -32.25% | -34.37% | -39.04% | -40.04% |
|
|
|||||
| Common Stock & APIC | 2.64% | 2.79% | 2.86% | 3.16% | 4,733.99% |
| Retained Earnings | -39.40% | -44.46% | -48.18% | -45.83% | -53.85% |
| Treasury Stock & Other | -63.33% | -77.36% | 240.38% | 323.38% | 830.93% |
| Total Common Equity | -32.47% | -30.23% | -27.31% | -22.85% | 273.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.47% | -30.23% | -27.31% | -22.85% | 273.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.47% | -30.23% | -27.31% | -22.85% | 9.15% |
|
|
|||||